The Case for and Against Buying NuScale Right Now

NuScale Power’s SMR story has strong tailwinds—NRC-certified design, U.S. government support to quadruple nuclear capacity by 2050, and partnerships targeting AI power demand—but the stock has fallen ~75% since last July to around $10 (vs. a $57 52-week high). The main overhang is the lack of a first firm commercial reactor sale and limited project momentum beyond the “talking phase,” making future economics hard to underwrite. With beta at 2.22, the article flags elevated volatility and likely ongoing turbulence as the company proves its concept.

Analysis

SMR is still an option on future utility procurement, not an operating business with a self-funding growth loop. The market is implicitly pricing a near-term conversion of narrative into bookings, but in nuclear the first binding contract matters far more than certifications or policy rhetoric; until then, every quarter of delay increases dilution risk and compresses terminal value. That makes the equity vulnerable to a classic “good story, bad balance sheet” setup where headline support can temporarily lift multiples but cannot anchor them.

The second-order winner from the AI power theme is likely not the reactor developer but the fastest deployable baseload alternatives: gas generation, grid infrastructure, and firms already monetizing power scarcity. For SMR and OKLO, the key competitive issue is not just who gets licensed first, but who can show a financeable, repeatable delivery model; if customers need certainty inside 24-36 months, nuclear loses share to interim solutions. In that sense, first-mover advantage decays quickly unless it converts into signed capacity and project financing.

Contrarian view: consensus is probably overvaluing long-dated optionality and underestimating execution drag. The stock can bounce hard on policy headlines, but the move is likely overdone relative to the probability of a real commercial milestone in the next 1-3 months. What would invalidate the bearish framing is a first firm sale with disclosed economics, site, and funding structure; without that, this remains a trading vehicle, not a fundamental compounder.

Key Decisions for Investors

• Tactically fade strength in SMR over the next 1-3 months; short only into headline-driven spikes and cover immediately if management announces a binding first commercial order or project financing.
• No fresh long in SMR until there is a signed customer, EPC path, and funding plan; treat any rally before that as sentiment-driven, not cash-flow-driven.
• If expressing the AI-power theme, prefer a relative long in a cash-generating power name versus SMR (e.g., long CEG / short SMR) for 1-3 months; the trade monetizes immediate power scarcity while avoiding binary execution risk.
• For higher-risk optionality, use a call spread only after a verifiable catalyst, not on policy headlines; otherwise the implied vol is likely too rich for a pre-revenue story.
• Watch OKLO as the cleaner barometer of speculative nuclear sentiment, but do not assume a rising tide lifts all SMR names; if OKLO re-rates without SMR booking progress, that is a negative relative signal for SMR.